DAWNRAYS PHARMA 02348
0.9600.00%( +0.000 )
Closed: Oct 9 · Delayed · Hong Kong Stock Exchange
DAWNRAYS PHARMA (02348) Insider Trading - Director Trades and Holdings - cibo
| Shareholder | Price | Type | Stake | ||||
|---|---|---|---|---|---|---|---|
| 熊融礼Executive Director | +84.00K | 0.97 | Bought | 606.12M | 40.22% | ||
| 李其玲Executive Director | +84.00K | 0.97 | Bought | 711.95M | 47.24% | ||
| 熊融礼Executive Director | +172.00K | 0.97 | Bought | 606.04M | 40.21% | ||
| 李其玲Executive Director | +172.00K | 0.97 | Bought | 711.86M | 47.24% | ||
| 熊融礼Executive Director | +96.00K | 0.98 | Bought | 605.86M | 40.20% | ||
| 李其玲Executive Director | +96.00K | 0.98 | Bought | 711.69M | 47.22% | ||
| 熊融礼Executive Director | +96.00K | 0.97 | Bought | 605.77M | 40.20% | ||
| 李其玲Executive Director | +96.00K | 0.97 | Bought | 711.60M | 47.22% | ||
| 熊融礼Executive Director | +76.00K | 0.98 | Bought | 605.67M | 40.19% | ||
| 李其玲Executive Director | +76.00K | 0.98 | Bought | 711.50M | 47.21% | ||
| 熊融礼Executive Director | +92.00K | 0.97 | Bought | 605.60M | 40.18% | ||
| 李其玲Executive Director | +92.00K | 0.97 | Bought | 711.42M | 47.21% | ||
| 熊融礼Executive Director | +64.00K | 0.98 | Bought | 605.50M | 40.18% | ||
| 李其玲Executive Director | +64.00K | 0.98 | Bought | 711.33M | 47.20% | ||
| 熊融礼Executive Director | +104.00K | 0.99 | Bought | 605.44M | 40.17% | ||
| 李其玲Executive Director | +104.00K | 0.99 | Bought | 711.27M | 47.20% | ||
| 熊融礼Executive Director | +60.00K | 0.99 | Bought | 605.34M | 40.17% | ||
| 李其玲Executive Director | +60.00K | 0.99 | Bought | 711.16M | 47.19% | ||
| 熊融礼Executive Director | +104.00K | 1.00 | Bought | 605.28M | 40.16% | ||
| 李其玲Executive Director | +104.00K | 1.00 | Bought | 711.10M | 47.19% | ||
| 熊融礼Executive Director | +72.00K | 1.00 | Bought | 605.17M | 40.18% | ||
| 李其玲Executive Director | +72.00K | 1.00 | Bought | 711.00M | 47.21% |
Changes in interests filed with HKEX by directors and chief executives. The bought/sold totals count long-position purchases and sales only; option exercises, grants and other events are left out.
| Shareholder | |||
|---|---|---|---|
| 李其玲Executive Director | 47.24% | 711.95M | |
| 熊融礼Executive Director | 40.22% | 606.12M | |
| 梁康民Non-Executive Director | 7.45% | 112.28M | |
| 李東明 | 5.06% | 40.11M | |
| 于麗偉 | 0.51% | 7.62M | |
| 吳偉賢 | 0.13% | 2.00M |
From the HKEXnews Disclosure of Interests complete list of directors: each director's long position after their latest filing.
This page shows share dealings filed by DAWNRAYS PHARMA (02348) directors and chief executives over the past year (date, shares, price, type and holding afterwards) with bought and sold totals, and each director's current holding. Data comes from the HKEXnews Disclosure of Interests (DI) section.
